Mega Lifesciences PCL (MEGA)

Currency in THB
36.25
0.00(0.00%)
Closed·
High dividend Yield
MEGA is included in our AI-picked strategies. See how they work
Fair Value
Day's Range
36.0036.50
52 wk Range
27.7540.00
Key Statistics
Bid/Ask
36.25 / 36.50
Prev. Close
36.25
Open
36.25
Day's Range
36-36.5
52 wk Range
27.75-40
Volume
474.7K
Average Volume (3m)
909.4K
1-Year Change
12.4031%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MEGA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
42.71
Upside
+17.83%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth

Mega Lifesciences PCL News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Analyst Ratings

6 Buy
1 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 42.71
(+17.83% Upside)

Mega Lifesciences PCL Earnings Call Summary for Q2/2026

  • Mega We Care reported Q2 2026 EPS of $0.59 on revenue of $3.53B; shares fell 1.3% to $38.00 amid concerns over higher spending and softer cash flow.
  • First-half revenue grew 11-12% with similar low-double-digit growth expected in H2 2026; management guided 8-12% growth for 2027 depending on product launches.
  • Core Mega We Care gross margin reached 65% in H1; SG&A at 32.5% of sales expected to decline in H2 as marketing expenses moderate throughout the year.
  • Company reaffirmed goal to double net profit by 2030 organically without M&A plans THB 2.6B capex through 2028 for plant upgrades and capacity expansion.
  • Operating cash flow at 76% of net profit signals inventory buildup; working capital cycle at 150-155 days while dividend payout ratio maintained near 70%.
Last Updated: 2026-09-01, 01:44 a/m
Read Full Transcript

Earnings

Latest Release
Aug 13, 2026
EPS / Forecast
0.59 / --
Revenue / Forecast
3.53B / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 2.51%
Dividend Yield
4.55%
Industry Median 4.29%
Annualized payout
1.65
Paid unevenly
5-Years Growth
+9.25%
Growth Streak

MEGA Income Statement

Compare MEGA to Peers and Sector

Metrics to compare
MEGA
Peers
Sector
Relationship
P/E Ratio
14.4x26.0x−0.4x
PEG Ratio
0.810.940.00
Price/Book
3.1x2.9x2.6x
Price / LTM Sales
2.2x3.2x3.0x
Upside (Analyst Target)
22.2%33.9%54.5%
Fair Value Upside
Unlock16.2%7.8%Unlock

Mega Lifesciences Public Company Limited, together with its subsidiaries, manufactures and sells health food supplements, prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods. The company operates through three segments: Brands, Distribution, and Original Equipment Manufacture. It offers wellness and nutrition products, including medical and sports nutrition, general well-being, vitamins, probiotics, herbal medicines, and cough and cold medicines, as well as hair, kid’s, men’s, and women’s care products; and various health concerns products, such as allergy, bone and joint, gut, liver, diabetic, eye, heart, brain, sleep and anxiety, pain, and skin care, as well as blood circulation and memory. The company also provides prescription medicines for anti-allergic, anti-infective, cardiovascular system, central nervous system, dermatology, diabetes, gastrointestinal, gynecology, nephrology, oncology, ophthalmology, orthopedic, pain, respiratory, rheumatology, and urology areas under the MEGA We care brand name. In addition, it offers logistical and marketing services for trading and sale of goods manufactured by third parties comprising warehouse management, collections, and value-added services; natural and plant-based health foods; digital support solutions; and operation of wellness center. Further, the company is involved in social enterprise; and software design, development, and other services. It sells its products in in Southeast Asia, Sub-Saharan Africa, Australia, Europe, and South America. Mega Lifesciences Public Company Limited was incorporated in 1982 and is headquartered in Bangkok, Thailand.

Employees
900
Market
Thailand

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
115.74M13.27%4.20B
Other Institutional Investors
-4.99M-0.57%-180.85M
Public Companies & Retail Investors
761.12M87.30%27.59B
Total
871.87M100.00%31.61B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Thai Life Insurance Public Company Limited1.89%16,477,200597,299
Norges Bank Investment Management1.87%16,301,301590,922

People Also Watch

44.50
KTB
+0.56%
151.00
SCB
+0.33%
61.00
GULF
+0.41%
154.00
PTTEP
-0.65%
353.00
ADVANC
-0.28%

FAQ

What Is the Mega Lifesciences (MEGA) Stock Price Today?

The Mega Lifesciences stock price today is 36.25 THB.

What Stock Exchange Does Mega Lifesciences Trade On?

Mega Lifesciences is listed and trades on the Thailand Stock Exchange.

What Is the Stock Symbol for Mega Lifesciences?

The stock symbol for Mega Lifesciences is "MEGA."

Does Mega Lifesciences Pay Dividends? What’s The Current Dividend Yield?

The Mega Lifesciences dividend yield is 4.55%.

What Is the Mega Lifesciences Market Cap?

As of today, Mega Lifesciences market cap is 31.61B THB.

What Is Mega Lifesciences's Earnings Per Share (TTM)?

The Mega Lifesciences EPS (TTM) is 2.51.

When Is the Next Mega Lifesciences Earnings Date?

Mega Lifesciences will release its next earnings report on Nov 16, 2026.

From a Technical Analysis Perspective, Is MEGA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Mega Lifesciences Stock Split?

Mega Lifesciences has split 0 times.

How Many Employees Does Mega Lifesciences Have?

Mega Lifesciences has 900 employees.

What is the current trading status of Mega Lifesciences (MEGA)?

As of Sep 15, 2026, Mega Lifesciences (MEGA) is trading at a price of 36.25 THB, with a previous close of 36.25 THB. The stock has fluctuated within a day range of 36.00 THB to 36.50 THB, while its 52-week range spans from 27.75 THB to 40.00 THB.

What Is Mega Lifesciences (MEGA) Price Target According to Analysts?

The average 12-month price target for Mega Lifesciences is 42.71 THB, with a high estimate of 45 THB and a low estimate of 35 THB. 6 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +17.83% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.